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a  b  s  t  r  a  c  t
The  cis-acting  replication  element  (CRE)  in the 2C protein  coding  region  [CRE(2C)]  of enteroviruses  (EV)
facilitates  the  addition  of two  uridine  residues  (uridylylation)  onto  the  virus-encoded  protein  VPg  in
order  for  it to  serve  as the  RNA  replication  primer.  We  demonstrated  that coxsackievirus  B3  (CVB3)  is
replication  competent  in the  absence  of a native  (uridylylating)  CRE(2C)  and  also  demonstrated  that  lack
of a functional  CRE(2C)  led  to generation  of 5′ terminal  genomic  deletions  in  the  CVB3  CRE-knock-out
(CVB3-CKO)  population.  We  asked  whether  reversion  of the mutated  CRE(2C)  occurred,  thus permitting
sustained  replication,  and  when  were  5′ terminal  deletions  generated  during  replication.  Virions  were
isolated  from  HeLa  cells  previously  electroporated  with  infectious  CVB3-CKO  T7 transcribed  RNA  or  from
hearts and  spleens  of  mice  after  transfection  with  CVB3-CKO  RNA.  Viral  RNA was  isolated  in  order  to
amplify  the  CRE(2C)  coding  region  and the  genomic  5′ terminal  sequences.  Sequence  analysis  revealed
reversion  of the  CVB3-CKO  sequence  to wildtype  occurs  by 8  days  post-electroporation  of  HeLa  cells
and  by  20  days  post-transfection  in  mice.  However,  5′ terminal  deletions  evolve  prior  to these  times.
Reversion  of  the  CRE(2C)  mutations  to wildtype  despite  loss  of  the  genomic  5′ termini  is  consistent  with
the  hypothesis  that  an  intact  CRE(2C)  is  inherently  vital  to EV  replication  even  when  it  is not  enabling
efficient  positive  strand  initiation.
© 2016  The  Authors.  Published  by  Elsevier  B.V. This  is  an  open  access  article  under  the  CC  BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
The group B coxsackieviruses (CVB; serotypes 1–6), are small,
non-enveloped, single-stranded RNA viruses classified as species
B enteroviruses (EV) [order Picornavirales;  family Picornaviridae;
genus enterovirus; species enterovirus B] (Pallansch et al., 2013).
Because the CVB cause, or are etiologically associated with, a
plethora of human diseases including aseptic meningitis, type I
diabetes, pancreatitis and myocarditis (Chapman and Kim, 2008;
Drescher et al., 2004; Modlin and Rotbart, 1997; Pallansch et al.,
2013; Tracy et al., 2011; Tracy et al., 2002), and because they
are common and typical enteroviruses, understanding how these
viruses replicate is especially relevant given current resurgence of
interest in enteroviral diseases such as those caused by enterovirus
A71 (Huang and Shih, 2014; Yip et al., 2013) and enterovirus D68
(Messacar et al., 2016; Tan et al., 2016).
Enteroviral persistence well after the acute infectious phase
has been documented [reviewed (Chapman and Kim, 2008)]. Per-
sistence of CVB RNA in the apparent absence of cytopathic virus
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populations in both tissues from experimentally-inoculated mice,
as well as from naturally infected humans, can occur well after both
the viremic phase and the rise of the type-specific adaptive immune
response to the infection (Chapman et al., 2008; Kim et al., 2008;
Kim et al., 2005; Leveque et al., 2012; Reetoo et al., 2000; Rey et al.,
2001; Tam and Messner, 1999; Tracy et al., 2015). Our previous
work identified the mechanism by which enteroviral persistence
can occur in the apparent absence of replicating virus, showing it
to manifest via naturally generated 5′ terminal genomic deletions
(CVB-TD) (Kim et al., 2005). Once arisen, CVB-TD populations per-
sist in the complete absence of intact wildtype virus populations
(Kim et al., 2008; Kim et al., 2005). Characterized CVB-TD popula-
tions exhibit 5′ terminal genomic deletions ranging from 7 to 49
nucleotides that partially erode domain I (Chapman et al., 2008;
Kim et al., 2008; Kim et al., 2005), a cis-acting replication element
(CRE) that is crucial for efficient EV genome replication (Andino
et al., 1993; Andino et al., 1990; Barton et al., 2001; Parsley et al.,
1997; Sean and Semler, 2008; Xiang et al., 1995). Studies have
demonstrated the generation of TD mutations in the heart and
the pancreas of mice inoculated with wildtype CVB3 (Kim et al.,
2005; Tracy et al., 2015), in the heart of a patient naturally infected
with CVB2 (Chapman et al., 2008) and during CVB3 passage in pri-
mary cell cultures but not in cultures of immortal cell lines such as
http://dx.doi.org/10.1016/j.virusres.2016.04.016
0168-1702/© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
0/).
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HeLa (Kim et al., 2008). CVB3-TD replicates in HeLa cells without
cytopathic effect (Kim et al., 2008; Kim et al., 2005) and to a level
100,000 fold less than the wildtype CVB3-28 (Smithee et al., 2015)
and produce infectious virion that can be neutralized with CVB3
specific antisera (Kim et al., 2005; Smithee et al., 2015). Prepa-
rations of CVB3-TD from HeLa cells demonstrate a nearly equal
level of positive and negative strands and encapsidate both positive
and negative strands (Kim et al., 2005). Passage of CVB3-TD with
short terminal deletions demonstrate evolution to larger deletions
in passage in mice (Kim et al., 2005) or in primary cell cultures (Kim
et al., 2008) but no reversion to wildtype virus, that is, reacquisition
of the deleted 5′ terminal sequence.
Located in the enteroviral protein 2C coding region is another of
4 known CREs [reviewed in (Paul and Wimmer, 2015)], a stem-loop
secondary structure termed CRE(2C). This structure is the template
for the viral RNA polymerase-mediated uridylylation of the viral
protein VPg; the VPg-pUpU is subsequently used to prime positive
strand viral RNA synthesis (Paul et al., 2003; Paul et al., 2000; van
Ooij et al., 2006). The CRE(2C) is therefore also crucial to EV replica-
tion: several genetically-engineered mutational disruptions of the
CRE(2C) of both poliovirus and CVB3 have been reported to be lethal
when studied using cell free assays to measure genome replication
and VPg uridylylation with autoradiographic analyses (Goodfellow
et al., 2003a; Goodfellow et al., 2003b; Murray and Barton, 2003;
van Ooij et al., 2006) or by luciferase and cytopathic effect assays
in cell cultures after short incubation times (van Ooij et al., 2006).
After engineering 16 CRE(2C) mutations [as in the DM mutant
shown by others (van Ooij et al., 2006) to be lethal for CVB3] into
our infectious copy of a CVB3 genome (Tracy et al., 2002) for use as
a negative control in other work, we were intrigued to find that this
CRE knockout construct (hereafter termed CVB3-CKO) was, in fact,
replication competent (Smithee et al., 2015). Ribonuclease-treated
and ultracentrifugally isolated infectious virions from HeLa cells
previously electroporated with T7 RNA polymerase-transcribed
CVB3-CKO RNA caused productive infections in fresh cell cultures
and were inhibited by anti-CVB3 neutralizing serum, confirm-
ing CVB3-CKO infectivity (Smithee et al., 2015). Interestingly,
we observed that 5′ terminal genomic deletions (TDs) had also
occurred in CVB3-CKO populations (Smithee et al., 2015). By inoc-
ulating mice with T7-transcribed CVB3-CKO RNA incorporated in a
transfection reagent (Smithee et al., 2015), we further showed that
infectious CVB3-CKO was generated in murine tissues by isolating
infectious virions and neutralizing their infectivity in cell culture
with anti-CVB3 serum. Together, these results demonstrated that
a functional CRE(2C) in a CVB3 genome was not required for the
induction of a productive CVB replication cycle.
The findings that CVB3-CKO is replication competent, although
severely diminished in replication efficiency vis-a-vis wildtype
CVB3, and that the CVB3-CKO had become 5′ terminally deleted
as well, led us to ask whether the mutated CRE(2C) sequence (CKO)
had remained intact or whether reversions in the sequence had
occurred. In a series of experiments to preliminarily examine this
question, we  repeatedly sequenced amplimers encompassing the
CRE(2C) region of CVB3-CKO isolated 8 days post-electroporation of
HeLa cells and observed that all 16 of the mutated CKO nucleotides
had reverted to wildtype. From these consistent results, we  drew
the conclusion that the CKO mutations were in fact reverting in
toto to the wildtype CRE(2C) sequence. Here, we  demonstrate
that following electroporation of cells with CVB3-CKO RNA, a new
CVB3 population arises with a reverted (that is, wildtype) CRE(2C)
sequence. We  also show that 5′ terminal genomic deletions evolve
in this virus population before the CKO reverts. Because the loss
of intact 5′ genomic termini lowers viral replication efficiency
(Smithee et al., 2015), it prevents the detectable CPE that would
be expected in cell culture had the CKO sequence reverted to the
wildtype CRE(2C) in the presence of an intact 5′ genomic terminus.
We suggest that the reversion to the wildtype CRE(2C) indicates
that a functional CRE(2C) contributes to CVB-TD replication.
2. Materials and methods
2.1. Cells and virus
Coxsackievirus B3/28 [described previously; (Tracy et al., 2002)]
is the (wildtype) virus strain used in this work. Mutations [as
described previously (Smithee et al., 2015; van Ooij et al., 2006)]
were made in the CRE(2C) region of the wildtype or CVB3-TD50
cDNA to create the CKO (cre knockout) strains, CVB3-CKO and
CVB3-TD50-CKO respectively (Fig. 1). All cDNA clones used in this
work were sequenced within the P-2C coding region to verify
the expected sequence with primers 2C2 and 2C7 (Table 1) as
described (Smithee et al., 2015). The CRE(2C) encoding region in
T7 transcribed RNAs were also reverse transcribed, then similarly
amplified and sequenced to verify the sequences were as expected
(Smithee et al., 2015). HeLa cell monolayer cultures were main-
tained as described previously (Smithee et al., 2015). Viral stocks
were prepared by electroporation of HeLa cells with T7 transcribed
RNA from infectious cDNA clones of each viral genome using a Gib-
coBRL Cell Porator (Gathersburg, MD,  USA) at 110 V, 1980 F, and
high ohms. Electroporated cell cultures were incubated for 1–8 days
(CVB3-CKO) or 8 days (CVB3-TD50, CVB3-TD50-CKO, and wild-
type CVB3). Following incubation with ribonuclease, virions were
Fig. 1. The CRE(2C) of CVB3 with mutations indicated. The sequence of the CRE(2C) of CVB3 from nucleotides 4367–4419. Nucleotides changed to generate CVB3-CKO are
indicated by italicized letters above the wildtype sequence. The numbering of the loop is indicated beginning with number 1 (G) and proceeding around the loop to number
14.  Red nucleotides in the loop indicate the template nucleotides used for VPg uridylylation (Paul et al., 2003). (For interpretation of the references to colour in this figure
legend,  the reader is referred to the web version of this article.)
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Table 1
Primer names, annealing sites and sequences.
Primer Name Region of CVB3/28 Genome Strand Nucleotide Sequence (5′ to 3′)
Sa 1–20 + TTAAAACAGCCTGTGGGTTG
S4a 45–74 + CGCTAGCACTCTGGTATCACGGTACCTTTG
S5b 86–113 + TATACCCCCTCCCCCAACTGTAACTTAG
SReturnb 291–312 – TACACTGGGGTAGTGCTGAGCG
E2a 450–464 + TCCGGCCCCTGAATG
E3subb 535–549 – AGTAGTCGGTTCCGC
E3a 537–563 – ACACGGACACCCAAAGTAGTCGGTTCC
2B1b 3746–3764 + GGAGTGAAGGACTATGTGG
2C1b 3944–3964 + ACTGCCACACTAGCCCTTATC
2C7b 4166–4186 + GAAAAACACGAATTCCTGAAC
2C2b 4450–4469 – CAATTAAGTTTGTTGCCACC
4523Revb 4523−4504 – GGTCTGGCGGTAGTGAGTAC
XBAb 4932–4958 – GCATGTCTAGAGAGTATCTGACCTGTG
PINb NA NA GGAATTCATCGATACGCGc
PIN5End1b 1–10 + GGAATTCATCGATACGCGTTAAAACAGCc
PIN5End5b 15–24 + GGAATTCATCGATACGCGGGGTTGATCCc
M13F(-20) NA NA GTAAAACGACGGCCAGc
a previously published in Kim et al., 2005.
b previously published in Smithee et al., 2015.
c underlined sequence is not genomic cDNA.
purified by ultracentrifugal pelleting through 30% (w/v) sucrose as
previously described (Smithee et al., 2015).
2.2. Transfection of mice with T7 transcribed viral RNA
The use and care of mice in these studies was approved by the
University of Nebraska Medical Center Institutional Animal Care
and Use Committee. Male A/J mice (6–7 weeks old; Jackson Labora-
tories, Bar Harbor, ME)  were inoculated intraperitoneally (i.p.) with
CVB3-CKO T7 transcripts as previously described (Smithee et al.,
2015). Briefly, mice were inoculated i.p. using a 1 mL  syringe with a
25 ga needle with 25 g of CVB3 or CVB3-CKO T7 transcribed RNA in
100 uL volumes, previously prepared in 0.4 mL  aliquots containing
100 g T7 transcribed RNA in 200 L of nuclease free water, 100 L
of LIPID-based in vivo Transfection Reagent (Altogen Biosystems),
20 L transfection enhancer, and 80 L of a 5% (w/v) sterile glucose
solution. After euthanizing mice and removing spleens and hearts,
total tissue RNA was extracted by homogenization in 0.5 mL  TRi-
zol (Invitrogen; Carlsbad, CA), then assayed as described for the
enzymatic amplification of the CRE(2C) sequence (below).
2.3. Enzymatic amplification of the CRE(2C) sequence from virus
RNA
To determine the sequence for reversions in the CRE(2C) regions
of CVB3-CKO and CVB3-TD50-CKO, we transcribed cDNA, enzy-
matically amplified the DNA, after which the amplimers were
treated as previously described (Smithee et al., 2015). Briefly,
cDNA was transcribed from viral RNA preparations (CVB3-CKO
[1, 3, 5, 6, 7, and 8 days post-electroporation]; CVB3-TD50-
CKO [8 days post-electroporation]; CVB3-TD50 control [8 days
post-electroporation]; wildtype CVB3 [pass 3, 8 days post-
electroporation]) as well as from day 20 post-transfection mouse
tissues (CVB3-CKO only) with primer 4523Rev (Table 1) at a
final concentration of 2 M using Improm II reverse transcriptase
(Promega, Madison, WI). Reactions containing 0.8 mM dNTPs, 2 mM
MgCl2, and 1 L enzyme (units not provided by supplier) in 20 L
reaction buffer were incubated for 60 min  at 42 ◦C. The CRE(2C)
region was amplified using nested primers in 20 L reaction vol-
umes containing GoTaq Green Master Mix  (Promega). Briefly, cDNA
was amplified in initial enzymatic reactions with primers 4523Rev
and 2B1 at a final concentration of 0.5 M (Table 1), with cycle
times as follows: one cycle at 94 ◦C for 5 min; 35 cycles at 94 ◦C for
10 s, 52 ◦C for 5 s, and 72 ◦C for 45 s with a final extension at 72 ◦C
for 5 min. PCR products were ethanol precipitated and resuspended
in 12 L of nuclease free water. A second enzymatic amplification
was done with primers 2C2 and 2C7 (Table 1) [cycle times were as
follows: one cycle at 94 ◦C for 5 min; 35 cycles at 94 ◦C for 10 s, 54 ◦C
for 5 s, and 72 ◦C for 45 s; and a final extension at 72 ◦C for 5 min].
For virion RNA preparations at days 6, 7 and 8 post-electroporation,
two concurrent amplifications with primers 2C2 and 2C7 were per-
formed in addition to, and in lieu of, the nested PCR described above;
this yielded better sensitivity at these time-points which had scant
viral RNA for cDNA preparation. Bands of amplified cDNA, elec-
trophoresed in 2% agarose, of the appropriate size (as predicted by
the annealing sites of primers in Table 1) were excised and puri-
fied using the Zymoclean Gel DNA Recovery Kit (Zymo Research;
Irvine, CA). Isolated DNA samples were sequenced at the UNMC
Core Facility.
2.4. Subcloning of CRE(2C) amplimers
To test whether intermediate populations were detectable, the
CRE(2C) region of CVB3-CKO at various time-points post electro-
poration of HeLa cells was enzymatically amplified as described
above. Amplimers were then ligated with pCR2.1 Topo vector
with a 3′-thymidine overhang and a covalently attached topoiso-
merase, and transformed into chemically competent E. coli (TOPO
TA Cloning Kit; Invitrogen; Carlsbad, CA) per manufacturer’s proto-
col. Insert-containing colonies were picked, inoculated into Terrific
Broth (Difco, BD, Sparks, MD), and incubated overnight at 37 ◦C
and 300 RPM. Plasmid DNA was isolated using Qiagen columns
(QIAprep Spin Miniprep Kit, Qiagen; Valencia, CA). Sequencing
was carried out with primer 2C7 (Table 1) at the UNMC High-
Throughput DNA Sequencing and Genotyping Core Facility.
2.5. Nested RT-PCR for detection of viral RNA in virus
preparations
To assay for viral RNA in ultracentrifugally isolated virion prepa-
rations, nested RT-PCR was performed as previously described
(Smithee et al., 2015). Briefly, cDNA was  primed with E3 (Table 1) as
described in enzymatic amplification of the CRE(2C) region (above),
followed by enzymatic amplification using primers S4 and E3Sub
(Table 1) in GoTaq Green Master Mix  (Promega). Cycle times for this
reaction were as follows: one cycle at 94 ◦C for 5 min; 35 cycles at
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94 ◦C for 10 s, 56 ◦C for 5 s, and 72 ◦C for 35 s with a final extension at
72 ◦C for 5 min. Reactions were ethanol precipitated and a second
PCR carried out using primers S5 and SReturn (Table 1) using cycle
times as follows: one cycle at 94 ◦C for 5 min; 35 cycles at 94 ◦C for
10 s, 56 ◦C for 10 s (based on gradient analysis), 72 ◦C for 35 s with a
final extension at 72 ◦C for 5 min. Final PCR products were analyzed
on 2% agarose gels. Amplimer bands of the expected size were puri-
fied, ligated with pCR2.1 Topo vector with a 3′-thymidine overhang
and covalently attached topoisomerase (TOPO TA Cloning Kit, Invit-
rogen, Grand Island, NY), and amplified in DH5 E. coli (Invitrogen).
Inserts in the plasmid DNA (QIAprep Spin Miniprep Kit, Qiagen)
were sequenced with M13  Forward (-20) Primer (Table 1).
2.6. Titering viral RNA in purified virus stocks using RT-qPCR
Because the mutant viruses (CVB3-CKO, CVB3-TD50, and CVB3-
TD50-CKO) do not cause CPE in tissue culture monolayers, viral RNA
copy number was determined using RT-qPCR as described previ-
ously (Kim et al., 2005; Smithee et al., 2015). cDNA was transcribed
with primer E3 (Table 1) as described in enzymatic amplifica-
tion of the CRE(2C) above. As previously described (Smithee et al.,
2015), RT-qPCR was performed using an Opticon 2 DNA Engine (MJ
Research) using primers E2 and E3Sub (Table 1) in Maxima SYBR
Green/Fluorescein qPCR master mix  (2X; Thermo Scientific). Cycle
times were as follows: one cycle at 94 ◦C for 5 min; 35 cycles at
94 ◦C for 10 s, 58 ◦C for 10 s, and 72 ◦C for 10 s with a final extension
at 72 ◦C for 30 s. Standard curves were generated by performing
10 fold serial dilutions of a 500 bp amplimer of CVB3 cDNA which
had been previously amplified from the CVB3/28 cDNA clone using
primers S and E3 (Table 1) and purified. The concentration of this
control DNA was determined using spectrophotometry at 260 nm.
2.7. RT-PCR to detect 5′ terminal deletions in RNA from purified
virus stocks
To determine when 5′ terminal genomic deletions occurred over
a time-course of CVB3-CKO replication, cDNA was primed with
E3 (Table 1). To provide comparable results, reverse transcriptase
reactions were each assembled with equal RNA copy numbers cal-
culated as described earlier (Smithee et al., 2015). Tagged primers
(Lanford et al., 1994) were used to detect 5′ terminal deletions
(Smithee et al., 2015). Briefly, initial enzymatic amplification was
carried out with E3 cDNA copy numbers determined to be over
but near the experimentally determined limit of detection for each
primer pair. For the primer pair, Pin5End1 and E3 (Table 1), this
copy number was 500 copies of E3 cDNA and for the primer pair,
Pin5End5 and E3 (Table 1) 1500 copies were used. Amplifications
were carried out in GoTaq Green Master Mix  (Promega), with cycle
times as follows: one cycle at 94 ◦C for 5 min; 35 cycles at 94 ◦C
for 10 s, 63 ◦C for 10 s, and 72 ◦C for 35 s; and a final extension at
72 ◦C for 5 min. Amplimers were ethanol precipitated, resuspended
in 12 L of nuclease free water and re-amplified in 20uL reactions
containing 8 L of the Pin5End1/5-E3 PCR product, 10 L of GoTaq
Green Master Mix  and primers Pin and SReturn (Table 1) at a final
concentration of 0.5 M.  Cycle times were as follows: one cycle at
94 ◦C for 5 min; 35 cycles at 94 ◦C for 10 s, 53 ◦C for 5 s, and 72 ◦C
for 25 s; and a final extension at 72 ◦C for 5 min. PCR products were
analyzed on 2% agarose gels.
2.8. Alignment of enterovirus B CRE(2C) protein and nucleotide
sequences
Enterovirus B nucleotide sequences in GenBank were aligned
with the enterovirus B reference nucleotide sequence (GenBank ID:
9626677) to compare the sequence encompassed by nt 4033–5019,
which encodes protein P-2C, using BLASTN 2.2.32+ with megablast
parameters (Morgulis et al., 2008; Zhang et al., 2000). The sequence
was compared to the wildtype CVB3/28 and CVB3-CKO sequences;
variations at positions with CKO mutations were noted. Similarly
enterovirus B protein sequences in GenBank were aligned with
the enterovirus B reference 2C protein sequence (GenBank ID:
25121824) using BLASTP 2.2.31+ (Altschul et al., 1997; Altschul
et al., 2005). The sequence was compared to the wildtype CVB3/28
and CVB3-CKO aa sequences, and to the predicted aa sequences in
which compensatory nucleotide mutations restored the ability of
the CKO CRE(2C) stem to form had reversions not occurred, in order
to determine if compensatory mutations were likely. The extent
to which these variations in the CRE(2C) aa sequence existed in
enterovirus B CRE(2C) sequences in GenBank was  noted.
3. Results
3.1. The 16 CKO mutations revert to the wildtype CRE(2C)
sequence
Earlier work (Smithee et al., 2015) demonstrated that CVB3-
CKO and CVB3-TD50-CKO are both viable in cell culture following
electroporation of T7 transcribed RNA; additionally, CVB3-CKO
replicated in mice following transfection of CVB3-CKO T7 RNA
polymerase-transcribed RNA. It was also demonstrated that
CVB3-CKO virion preparations isolated from HeLa cell cultures
post-electroporation, or from mouse tissue homogenates, could
subsequently be detected after passage in cell culture, and that
such infections were prevented when using anti-CVB3 neutralizing
serum (Smithee et al., 2015). The fact that we observed replication
of CVB3-CKO was  contrary to previous results which indicated the
mutations in the enterovirus CRE(2C) (Fig. 1) were lethal (Murray
and Barton, 2003; van Ooij et al., 2006). Perhaps reversions were
occurring, permitting this replication. We  therefore asked whether
the 16 mutations introduced in the CRE(2C) region of CVB3-CKO
remained intact during replication, or whether reversions occurred
in this region after replication in either cell culture or within the
tissues of transfected mice. T7 transcribed full length RNA was elec-
troporated into HeLa cell cultures to provide virion preparations
(CVB3-CKO or CVB3-TD50-CKO [wildtype CVB3 and CVB3-TD50
were used as controls]) for preparation of viral cDNA. Viral cDNA
was also prepared from RNA of mouse tissues at 20 days post trans-
fection with CVB3-CKO RNA. The CRE(2C) region was enzymatically
amplified and sequenced from these viral cDNAs; wildtype and
CVB3-CKO clones were used as sequencing controls. Alignments of
amplified CRE(2C) sequences were subsequently performed (Fig. 2).
Sequencing results from total amplimer populations indicated
that at days 1, 3 and 5 (Fig. 2A, rows 5,6,7) post-electroporation of
HeLa cell cultures with CVB3-CKO T7 transcribed RNA, the 16 muta-
tions in the CRE(2C) region were intact: no reversions were evident
in purified CVB3-CKO virion RNA when compared to the wild-
type CVB3 cDNA clone and T7 transcribed RNA (Fig. 2A, rows 1,2
respectively) or the CVB3-CKO cDNA clone and T7 transcribed RNA
(Fig. 2A, rows 3,4 respectively). However, by day 8 post electropora-
tion, all 16 mutations had reverted to that of the wildtype sequence
(compare Fig. 2A, rows 8,9 to rows 1,2 [wildtype] and rows 3,4
[CVB3-CKO]): we  observed this result in 4 separate and repeat
experiments using different and individually purified CVB3-CKO
virion preparations from day 8 post-electroporation cell cultures (of
which two representative sample sequences are shown in Fig. 2A,
rows 8,9). To determine whether reversions were present in virion
RNA isolated from murine tissues at day 20 post transfection, the
CRE(2C) region was amplified using the same method described for
the purified virion preparations. Analysis of sequences from day
20 post-transfection heart (Fig. 2A, row 10) and spleen (Fig. 2A,
row 11) also demonstrated that reversion to the wildtype sequence
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Fig. 2. The CRE(2C) of CVB3-CKO completely reverts to a wildtype sequence by 8 days post-electroporation in HeLa cells and by 20 days post-transfection in mouse tissues.
(A)  Sequence alignments of cDNA clones (1 [wildtype CVB3] and 3 [CVB3-CKO]), T7 transcribed RNA from cDNA clones (2 [wildtype CVB3] and 4 [CVB3-CKO]), RNA from
purified virus preparations at various time-points post-electroporation of HeLa cells (5 [CVB3-CKO 1 day post-electroporation], 6 [CVB3-CKO 3 days post-electroporation],
7  [CVB3-CKO 5 days post electroporation], 8 [CVB3-CKO 8 days post-electroporation; virus preparation I], 9 [CVB3-CKO 8 days post-electroporation; virus preparation II],
12  [CVB3-TD50-CKO 8 days post-electroporation], and 13 [CVB3-TD50 8 days post electroporation]), and mouse tissues 20 days post-transfection (10 [CVB3-CKO; mouse
heart]  and 11 [CVB3-CKO; mouse spleen]). Underlined nucleotides indicate wildtype sequence and red, underlined sequence indicates CKO mutations. (B-D) Representative
sequence chromatograms from (B) CVB3-CKO at 1 day post-electroporation of HeLa cells, (C) 5 days post-electroporation, and (D) 8 days post electroporation. 2A, line 5: R
is  the IUPAC designation for a mixture of purine at this position.
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had occurred in the CRE(2C) region of CVB3-CKO (compare Fig. 2A,
rows 10,11 respectively, to rows 1,2 and rows 3,4). The same result
was obtained using another set of mouse tissues from different
mice at the same time point (data not shown). A representative
selection of sequencing chromatograms from days 1, 5, and 8 post-
electroporation of cell culture demonstrate that sequencing reads
were unambiguous (Fig. 2B,C,D). Together, these results indicated
that reversion of CKO to wildtype sequence in the CRE(2C) encod-
ing region had occurred and that this was detectable after 8 days in
cell culture or following 20 days of replication in murine tissues.
3.2. CKO also reverts in a CVB3 genome lacking wildtype 5′
genomic termini
We  then engineered the CKO mutations into an infectious cDNA
cloned genome [CVB3-TD50; (Kim et al., 2005)] which lacked the
49 5′ terminal genomic nucleotides; this was termed CVB3-TD50-
CKO (Smithee et al., 2015). We  reasoned that CVB3-TD50-CKO
should not require uridylylated VPg as a primer for RNA replica-
tion because unlike the wildtype genome, the genomic 5′ terminus
is CG (Kim et al., 2005). As we had observed reversion of the 16
mutations in the CRE(2C) sequence of CVB3-CKO RNA after 8 days
of replication in HeLa cells as well as at 20 days in the tissues of
transfected mice, we asked whether reversions of the mutated sites
also occurred in CVB3-TD50-CKO. Using CVB3-TD50 as a control,
sequence analysis was conducted on CVB3-TD50-CKO and CVB3-
TD50 as described above for CVB3-CKO. Based on sequence analysis
at 8 days post-electroporation of HeLa cells, reversion of the 16
CKO mutations to wildtype sequence occurs in the CVB3-TD50-CKO
population as well (compare Fig. 2A, row 12 to row 13 and row 12
to rows 1,2 [wildtype] and rows 3,4 [CVB3-CKO]). These findings
indicated that whether or not the viral 5′ genomic termini were
intact when replication was initiated, the CKO sequences reverted
and were indistinguishable from those of the wildtype CVB3.
While we had observed reversion of CKO to the wildtype
CRE(2C) sequence after 8 days of replication in HeLa cells, the
sequence of total amplified cDNA populations prior to the 8 day
time point showed only the expected genetically engineered CKO
mutations. We  hypothesized that prior to 8 days, populations of
CRE(2C) revertants were continually forming and collapsing within
each infected cell’s mutant swarm but that the residual domi-
nant sequence (CKO) in the total amplimer population effectively
masked these changes (Borderia et al., 2010). This suggested that
the wildtype (revertant) CRE(2C) population would have to be the
dominant sequence before being able to be detected by sequence
analysis. Thus, at some ratio of the mutant CKO sequence to the
wildtype CRE(2C) sequence, the wildtype sequence (or any other
variant of the mutant swarm) would not be detectable by Sanger
sequencing analysis. We  therefore determined the ratio of wild-
type CRE(2C) to CKO sequences that would need to be present in
a mixed population before the wildtype CRE(2C) sequence could,
and the CKO sequence could not, be detected using Sanger sequenc-
ing. Increasing concentrations of wildtype CVB3 cDNA were mixed
with a constant concentration of CVB3-CKO cDNA. Thus, two-
fold increases of the wildtype CVB3 cDNA clone (from 1.62 × 109
copies [1:1] to 1.30 × 1010 copies [8:1]) were mixed with a con-
stant copy number of the CVB3-CKO cDNA clone (1.62 × 109 copies).
The CRE(2C) region was  then amplified from these mixtures and
sequenced using primer 2C7 (Table 1), after which sequencing chro-
matograms were compared (Fig. 3). The control CVB3-CKO and
wildtype CVB3 clone DNA sequences were as expected (Fig. 3A,
F), confirming that the expected CKO mutations were present in
the CVB3-CKO cloned cDNA used in these studies. At a cDNA copy
ratio of 1:1 [wildtype CRE(2C)/CVB3-CKO (Fig. 3B)] both sequences
were detected, as shown by the presence of two peaks correspond-
ing to two different nucleotides in the sequencing chromatogram.
However, at a copy ratio of just 2:1 wildtype CRE(2C)/CVB3-CKO
(Fig. 3C), the mutant CKO sequence is already partially obscured
by the two-fold majority wildtype sequence: this is indicated by
the finding that 10 of the 16 mutations may  be read as wildtype in
the chromatogram, although two  peaks were still evident at each
mutation site (Fig. 3C, arrows). At a ratio of 4:1 or 8:1, (Fig. 3D, E), all
16 CKO mutations are effectively masked by the wildtype sequence.
Minor secondary peaks were detected in the sequencing chro-
matogram in these regions; such minor peaks are also observed in
chromatograms of CVB3-CKO or wildtype plasmids alone (compare
Fig. 3A, F to Fig. 3D, E). This indicated that when exploring a pop-
ulation of replicating RNA sequences 8 days post-electroporation
with CVB3-CKO T7 transcribed RNA, only the majority population
would be detectable at any time using standard Sanger sequenc-
ing. Intermediate populations would have to be present at a ratio
of greater than 2:1 reverted:mutant in order to be detected using
this approach. The strong inference is when reversion to wildtype of
a CKO genome finally occurs, the new wildtype population rapidly
predominates without the appearance of other stable and populous
intermediates.
3.3. Reversion of CKO to wildtype CRE(2C) is not artifactual
Contamination with wildtype CVB3 RNA represented an obvi-
ous and trivial explanation for the observed reversion of 16 nt in
the CKO to wildtype CRE(2C). Because we  were using replication
competent viral genomes, we  used biological amplification (viral
replication) as the most sensitive assay to test this hypothesis. A
valid and sensitive assay to discriminate between wildtype CVB3
and the CKO strains or any of the CVB3-TD strains, is the induction
of CPE for it has been clearly demonstrated that only wildtype CVB3
induces complete CPE in susceptible cell cultures, whereas neither
CVB3-TD nor CVB3-CKO strains induce detectable CPE (Kim et al.,
2008; Kim et al., 2005; Smithee et al., 2015). To test the hypothesis
that contamination may have been responsible for our observa-
tions, we reasoned that if very few wildtype CVB3 genomes (which
is to say, essentially undetectable levels by molecular means) were
co-transfected with a gross excess of the replication impaired
CVB3-CKO genomes, we would nonetheless observe the genera-
tion of CPE in the cell culture as the result of the dominance of
the wildtype replication due to the 5 orders of magnitude differ-
ence in replication efficiency (Smithee et al., 2015) between these
populations in HeLa cells. This was  tested by transfecting mixes
of T7-transcribed wildtype (cytopathic) CVB3 RNA and CVB3-CKO
RNA into HeLa cell monolayers; the number of wildtype CVB3 RNA
genomes ranged between 10 and 1000 copies while the copy num-
ber of (non-cytopathic) CVB3-CKO T7 transcribed RNA was held
constant at 1.97 × 1011 copies. These mixes thus represented CVB3-
CKO/wildtype CVB3CRE(2C) copy ratios of 2 × 1010–2 × 108 to 1.
Previous work by Crowder and Kirkegaard demonstrated that when
one or two  mutations were induced in the stem of the poliovirus
CRE(2C), a dominant negative effect occurred during co-infection
with wildtype poliovirus (Crowder and Kirkegaard, 2005); how-
ever, when multiple mutations throughout the stem and loop of
the CRE(2C) were introduced (similar to those of CKO), no inhibi-
tion of wildtype virus replication occurred following co-infection
(Crowder and Kirkegaard, 2005). Therefore, we  did not anticipate a
dominant negative effect on the replication of wildtype CVB3 from
the structural disruption of the CRE(2C) sequence in CVB3-CKO.
Following transfection of HeLa cell monolayers with the different
viral RNA ratios, cultures were observed daily for the presence of
CPE. In all cultures transfected only with wildtype RNA, complete
CPE was observed after 24 h. Complete CPE was  also observed in
monolayers which had been transfected with both RNA types at
100 and 1000 copies of wildtype CVB3 RNA plus CVB3-CKO RNA
(Table 2). Importantly, CPE was  never observed in wells transfected
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Fig. 3. Standard Sanger sequence analysis is inefficient at detecting mutations in a mixed population. (A-C) Sequencing was conducted on mixed population of cDNA clones
of  wildtype CVB3 and CVB3-CKO, with the concentration of CVB3-CKO being held constant and the concentration of wildtype CVB3 increasing by 2-fold to a final ratio of
8:1;  underlined nucleotides indicate the 16 nucleotides mutated to generate CVB3-CKO from wildtype. (A) The DNA sequence of the CVB3-CKO CRE(2C) region using primer
2C7  (Table 1). (B) A 1:1 ratio of wildtype:CVB3-CKO demonstrates that both sequences are detected at near equal efficiency as indicated by double peaks (the box highlights
a  representative region with double peaks) and nucleotide ambiguity codes at positions corresponding to variable regions (red arrows). (C) At a ratio of 2:1, the wildtype
sequence begins to obscure and mask the CKO sequence with only 6 of the 16CKO mutations detectable (red arrows). (D-F) At a ratio of 4:1 wildtype:CVB3-CKO (D) and 8:1
wildtype:CVB3-CKO (E), the CKO mutations are no longer detectable as compared to the wildtype cDNA clone sequence chromatogram (F).
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Table  2
Experimental contamination of CVB3-CKO T7 transcribed RNA transfections with wildtype CVB3 T7 transcribed RNA demonstrate wildtype CVB3 rapidly becomes dominant.
T7 transcribed RNA
Input
(CVB3-CKO constant
At 1.97 × 1011)
CPE
Present 1 day
post
transfection
CPE
Present 5 days
post
transfection
CPE
Present 1 blind
passage
CPE
Present 2 blind
passages
CPE
Present 3 blind
passages
CVB3-CKO only NO NO NO NO NO
CVB3-CKO +
10 copies wildtype CVB3
NO NO NO YES Not Tested
CVB3-CKO +
100 copies wildtype CVB3
YES YES YES YES Not Tested
CVB3-CKO +
1000 copies wildtype CVB3
YES YES YES YES Not Tested
wildtype CVB3 only
1.97 × 1011 copies
YES YES YES YES Not Tested
wildtype CVB3 only
10 copies
NO YES YES YES Not Tested
wildtype CVB3 only
100 copies
YES YES YES YES Not Tested
wildtype CVB3 only
1000 copies
YES YES YES YES Not Tested
only with CVB3-CKO RNA alone or in mock-transfected cultures. In
wells transfected with just 10 copies of wildtype T7 transcribed
RNA and the excess of CVB3-CKO RNA, CPE was not observed by
5 days post-transfection (Table 2). However, when freeze-thawed
lysates of cells in these wells were passaged to fresh cell cultures,
CPE was evident after two passages (5 days of incubation follow-
ing each passage). This delayed CPE was likely due to the relative
difficulty of repeatedly measuring 10 RNA molecules with abso-
lute precision for the initial transfection. It is important to note
with respect to the latter finding that in no case (1–3 passages
of 5 days each) did lysates from the controls (cultures transfected
only with CVB3-CKO RNA) cause CPE on cell cultures. These results
demonstrated, along with previous observations that passage of
CVB3-CKO purified virus preparations do not induce CPE (Smithee
et al., 2015), that CVB3-CKO virus preparations which were assayed
for reversions were not contaminated with wildtype CVB3 and fur-
ther, did not revert to a wildtype phenotype (ability to induce CPE)
during passage. Contamination of PCR primers was  also ruled out by
conducting 10 replicate enzymatic amplifications containing only
water, enzyme mix, and primers 2C2 and 2C7 (Table 1), all of which
were negative for amplified cDNA when assayed on 2% agarose gels
(data not shown).
3.4. Stable compensatory mutations are not predicted to occur in
the stem of CRE(2C) in CKO viruses
We  were curious to determine whether stable, partially reverted
CVB3-CKO populations might arise. The mutations in the stem
of the CKO mutant (Smithee et al., 2015; van Ooij et al., 2006)
(Fig. 1) were synonymous, third-base mutations within codons in
the protein 2C coding region. However, those nucleotides which
pair with the mutated nucleotides are either in first or second posi-
tions within the 2C codons. Thus, any single compensatory change
in the opposite strand to allow the CRE(2C) structure with the
CKO mutation would result in an amino acid coding alteration.
We aligned predicted 2C protein amino acid sequences of avail-
able enterovirus species-B in GenBank to identify all variations that
have been reported. Of the seven predicted compensatory muta-
tions which could restore the stem of CRE(2C), six would produce
amino acid variants not reported to GenBank and only one had a
variation which was reported; it was present in just one of 429
reported 2C amino acid sequences (Fig. 4A,B; boxes and arrows),
suggesting much lower fitness of the viruses carrying these vari-
ants. This analysis indicated that it would be highly unlikely that
stable compensatory mutations could be selected in the stem of the
CRE(2C).
We also aligned all available CRE(2C) loop sequences of EV-B
(more than 400 in GenBank). Of the 8 loop mutations engineered
in the CKO construct, two were found just once in 425 aligned EV-B
loop sequences and one was found in 3 of 416 EV-B aligned loop
sequences. The high degree of CRE(2C) loop sequence conserva-
tion may  not be surprising given the observed deleterious effects
on uridylylation of mutations at several positions in the loop (van
Ooij et al., 2006). Because the CRE(2C) loop is also part of a coding
sequence with a defined secondary structure, the adoption of stable
nucleotide changes which alter coding capacity and/or structure of
this region would be even less likely. Taken together, these anal-
yses indicated that viral genomes with partially reverted CRE(2C)
sequences would not have high fitness and would likely not be a
major component of the population.
3.5. Inability to capture intermediate forms of the reverting CKO
sequence by PCR amplification
Total amplimer sequencing failed to show revertants prior to
observation of reversion of all 16 mutations (above). Control exper-
iments (above) demonstrated that at a 4:1 ratio of one sequence
to another divergent sequence, sequence analysis of the dynamic
population was an insufficiently sensitive detection assay for minor
variants. Analyses of known CRE(2C) sequences had indicated that
changes from the wildtype CRE(2C) would be inconsistent with a
viable and stable virus population. However, we attempted to iso-
late and characterize intermediate reversion forms of the sequence
through sequencing of amplimers derived from viral RNA 5, 6, and
7 days post-electroporation to test whether one or more minor,
yet stable, populations might inapparently exist below the level of
our detection. Nested PCR was  performed on cDNA from four dif-
ferent CVB3-CKO RNA preparations as described above (Smithee
et al., 2015) and 8 individual insert-positive colonies were assayed
at each time point for each PCR. No intermediate (i.e., altered from
CKO) sequences were observed: the 16 CKO mutations remained
intact at each time point for all clones analyzed. We  performed
similar experiments on viral RNA from cultures at day 8: in these,
all sequences were wildtype (data not shown). No CKO or partial
revertant sequences were present in any of the 32 sequences ana-
lyzed, which corresponded to four different, ribonuclease treated
and biophysically purified 8 day CVB3-CKO virion preparations.
These results suggest that despite it being certain that intermedi-
ate revertant populations are constantly being generated (e.g., 3 of
22 clones of an 5′NTR region of similar size from these virus prepa-
rations had variations from the original plasmid cDNA sequence;
data not shown), the consensus sequence detected prior to 8 days
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Fig. 4. Compensatory mutations are unlikely in the stem of the CRE(2C). (A) Sequence analysis using NCBI was used to explore the possibility of compensatory mutations in
the  CRE(2C) of CVB3. Potential amino acid variations resulting from compensatory mutations to restore the CRE(2C) RNA structure are noted. All variations in the CRE(2C)
encoding sequence that would affect the amino acid sequence of the 2C protein are noted. Only 1 amino acid variation identical to those resulting from compensatory
mutations was reported to exist in 429 EV-B 2C aa sequences examined (box and arrows). (B) Location of this compensatory mutation in the CRE(2C) secondary structure
(box).
post-transfection was CKO. This is consistent with the hypothesis
that none of the intermediates were able to establish a temporary
stable dominance until complete reversion of a CKO genome to the
wildtype CRE(2C) sequence occurred, whereupon that genome was
strongly selected. The possibility of exploring this interesting find-
ing using more advanced sequencing techniques, such as RNAseq
(Wilhelm and Landry, 2009) or CirSeq (Acevedo and Andino, 2014),
was also considered; however this was impractical due to the low
level of RNA available from virus preparations. For example, a sin-
gle 100 mm dish of HeLa cells at 8 days post electroporation yielded
on the order of 100,000 copies of viral RNA (Smithee et al., 2015)
or the equivalent to approximately 4.0 × 10−7g. With the average
RNAseq experiment requiring greater than, or equal to, 5 g of RNA,
we would have required the viral RNA yield from approximately
1–2 × 107 100 mm dishes per experiment or 2.5 × 104 dishes for
more sensitive next generation sequencing requiring 10 ng RNA.
3.6. 5′ terminal genomic deletions occur before the CKO sequence
reverts to wildtype
Previous work demonstrated that the CVB3-CKO population had
lost as many as 20 nucleotides from the 5′ genomic terminus in
the majority population by day 8 post electroporation of HeLa cells
(Smithee et al., 2015). This phenomenon of 5′ genomic terminal
sequence loss in CVB populations can occur naturally after experi-
mental inoculation of mice and primary cell cultures, as well as after
natural infection in humans, leading to persistent, low-level infec-
tions (Chapman et al., 2008; Kim et al., 2008; Kim et al., 2005; Tracy
et al., 2015). Although the engineered 16 mutations in the CRE(2C)
that results in the CKO sequence is not a natural occurrence, the
replication of CVB3-CKO is a persistent low-level replication simi-
lar to populations with 5′ terminally deleted genomes. We  wanted
to determine whether 5′ terminal deletions occurred prior to rever-
sion of the CRE(2C): we anticipated this would be the case because,
were reversion of the CKO occurring prior to the generation of 5′
terminally deleted genomes, the population of CVB3-CKO would
become wildtype [with a natural CRE(2C) and intact 5′ genomic ter-
mini] and CPE would therefore be detectable in cell culture. Of note,
however, CPE was not observed with CVB3-CKO (Smithee et al.,
2015). Therefore, we analyzed the 5′ genomic termini of RNA from
purified virion preparations of CVB3-CKO at days 1, 3, 5, 6, 7, and 8
post electroporation, as described above and previously (Smithee
et al., 2015), to test whether 5′ terminal genomic deletions were
occurring. These results demonstrated that at days 1 and 3 post-
electroporation, purified CVB3-CKO virion RNA showed intact 5′
genomic termini when compared to the wildtype CVB3 virus con-
trol or the CVB3-CKO T7 transcript control (compare Fig. 5A lanes
2 and 3 [1 day] and lanes 5 and 6 [3 days] to Fig. 5B, lanes 11 and 12
[wildtype virus] and Fig. 5C, lanes 11 and 12 [T7 transcript control]).
However, by day 5 post-electroporation, the CVB3-CKO popula-
tion had evolved into a 5′ terminally deleted population (compare
Fig. 5A, lanes 8 and 9 [5 days], lanes 11 and 12 [6 days], Fig. 5B,
lanes 2 and 3 [7 days], lanes 5 and 6 [8 days preparation 1], and
lanes 8 and 9 [8 days preparation 2] to Fig. 5A, lanes 2 and 3 [1 day],
lanes 5 and 6 [3 days], Fig. 5B, lanes 11 and 12 [wildtype virus],
and Fig. 5C, lanes 11 and 12 [T7 transcript control]). As a control
to determine whether virus was  indeed present in all preparations,
RT-PCR with primers that anneal in a region of the 5′ NTR that has
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Fig. 5. 5′ terminal deletions occur between days 3 and 5 post electroporation of HeLa cells with CVB3-CKO T7 transcribed RNA. To detect 5′ terminal deletions agarose gel
analysis of E3 primed cDNA amplified with primers Pin5End1 and E3 corresponding to nucleotides 1–10 and the 5′ genomic terminus (A-C lanes 2, 5, 8, and 11) Pin5End5
and  E3 corresponding to nucleotides 15–25 (A-C lanes 3, 6, 9, and 12), then subsequently amplified with primers Pin and SReturn was performed. To detect virus using a
region of the 5′ NTR not found to delete, gel analysis of E3 primed cDNA amplified with primers S4 and E3Sub (A-C lanes 4, 7, 10, and 13), then subsequently amplified with
primers S5 and SReturn was performed. 500 (Pin5End1; S4) or 1500 (Pin5End5) copies of cDNA prepared from either viral RNA or T7 transcribed RNA (control) were used in
each  PCR reaction. Right facing (red) arrows indicate the loss of sequence from the 5′ terminus of CVB3-CKO by day 5, 6, 7, 8 post-electroporation as compared to wildtype
virus  and T7 transcript controls or to CVB3-CKO at days 1 and 3 post-electroporation (left facing (black) arrows]. Controls: lanes C2-4, no cDNA PCR controls; lanes C5-7 no
template RT-PCR controls; lanes C8-10 tissue culture controls.
not been found to delete, even when the 5′ genomic terminus was
not detected (E3, E3sub, E2, S5 and SReturn; Table 1), were used
with nested RT-PCR for detection of viral RNA in virus preparations
(compare Fig. 5A, lane 4 [1 day], lane 7 [3 days], lane 10 [5 days],
lane 13 [6 days], Fig. 5B, lane 4 [7 days], lane 7 [8 days preparation
1], lane 10 [8 days preparation 2], and lane 13 [wildtype] to Fig. 5C,
lane 13 [T7 transcript control]). When compared to sequencing data
(Fig. 2), these results show that 5′ TDs were occurring between day
3 and 5 post-transfection, well before detection of the reversion of
CKO to that of the CRE(2C) wildtype sequence at day 8 [compare
Fig. 5, which demonstrates loss of 5′ genomic terminus between
days 3 and 5 post-electroporation (Fig. 5A, lanes 5 and 6; lanes 8
and 9 respectively) to Fig. 2 demonstrating that at 5 days post-
electroporation the majority population remains a CKO population
(Fig. 2, row 7)].
4. Discussion
Genetically engineered mutational disruptions of enteroviral
CRE(2C) sequences are reported as either significantly deleterious
or lethal for replication (Goodfellow et al., 2000; Goodfellow et al.,
2003a; McKnight and Lemon, 1998; Morasco et al., 2003; Murray
and Barton, 2003; van Ooij et al., 2006). Both single and multiple
mutations hamper important aspects of CVB3 replication (van Ooij
et al., 2006). A 16 nucleotide mutant [termed DM by van Ooij et al.
(24) or CKO in this report], as well as single nucleotide mutants,
demonstrated diminished levels of VPg uridylylation and single-
stranded viral genomes (but not of the double-stranded replicative
form or RF). Virus-encoded luciferase also showed a decrease to
background levels in transfected cells, indicating that the expres-
sion of proteins encoded by viruses with a disrupted CRE(2C) was
extremely low (van Ooij et al., 2006). However, previous work
(Smithee et al., 2015) demonstrated that CVB3-CKO virus is indeed
viable, replicating in cell culture and in animals, but at a level similar
to that observed in naturally occurring CVB-TD virus populations
(Smithee et al., 2015), a level that permits persistence in tissues but
not enough to achieve detectable CPE. Clearly detection of CPE is
an insufficiently sensitive method to assess viability of such virus
populations.
The observed generation of 5′ terminal genomic deletions in
replication of the CKO genomes was  surprising, but given the low
level of replication, suggested a strong effect of the CRE(2) muta-
tions upon positive strand initiation (Smithee et al., 2015). The
complete reversion of the mutations in the context of 5′ termi-
nal deletions was also unexpected. Contamination with infectious
wildtype CVB3 cDNA or RNA does not explain our findings. Had
even a minor population of wildtype CVB3 (that is, 1–10 infectious
units) been present, the rapidity of wildtype virus population repli-
cation would have produced detectable CPE: this was not observed
when tested. Transfection experiments were performed in which
10-fold increases in wildtype CVB3 T7 transcribed RNA (from
10–1000 copies) were transfected with a constant concentration
of CVB3-CKO T7 transcribed RNA (Table 2). Importantly, CPE was
not observed even after three passages of purified CVB3-CKO virus
in HeLa cell culture, indicating contamination with wildtype CVB3
had not occurred. Sequence analysis also argues against contami-
nation. By sequencing mixed populations of wildtype CVB3 cDNA
and CVB3-CKO cDNA, we determined that a wildtype CRE(2C) must
represent about 25% of a mixed population in order to be detected
by standard Sanger sequencing employed in this study. Thus, by
the time the wildtype CRE(2C) sequence was  detectable in a mixed
virus population, it is reasonable to assume the wildtype popu-
lation would have been well on the way  to becoming dominant
given the advantage of more rapid replication. This rapid collapse
(Garcia-Arriaza et al., 2006) of one (CKO) quasispecies population
and the rapid succession of the other (wildtype) population, not
contamination, explains the inability to detect intermediate CRE
sequences by cloning: stable populations (beginning with CVB3-
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CKO and ending with wildtype CVB3) are the only significantly
populous genomic groups. With standard Sanger sequence analy-
sis being a relatively inefficient detection assay, such changes were
masked until the new wildtype master sequence was  generated,
whereupon it became the dominant (detectable) sequence. As we
observed that CVB3-CKO generated a TD population days before the
reversion to wildtype CRE(2C) was apparent, the increase in fitness
of the CRE(2C) reversion was not as apparent as reversions in non-
TD genomes. Notably, this occurred in HeLa cells, a transformed cell
line in which CVB-TD populations have not been observed to arise
(Kim et al., 2005): therefore, for contamination to have validity as
an explanation for the results reported here, it would have required
that the input virus population were also a CVB3-TD strain. It is clear
that contamination is not a rational explanation for these data.
Genetic changes at numerous loci are not saltatory, which is to
say it is not immediate: there is a period of time during which such
changes occur. However, this does not necessarily imply that the
time required is directly related to the number of changes: this pro-
cess is affected by diverse forces (Garcia-Arriaza et al., 2006). If, as
in the case we report here, a new multi-locus sequence seems to
‘suddenly’ arise, it may  give the (mistaken) impression that the var-
ious reversions occurred in one or very few replication cycles. The
chain of events leading to this reversion was subject to numerous
pressures. de la Torre and colleagues, for example, observed some-
thing similar with a smaller set of mutations, finding it remarkable
that ". . .four silent mutations reverted together or not at all”: 4
sites in the 3AB domain of poliovirus had rapidly and completely
reverted after 7 days of incubation in HeLa cell culture with no
detection of intermediate populations, a finding that could not be
adequately explained at the time (de la Torre et al., 1992). Previ-
ously, de la Torre et al. also demonstrated rapid specific reversion of
single-nucleotide, guanidine-resistance inducing mutations in the
poliovirus 2C coding region which resulted in a wildtype guanidine-
sensitive phenotype in HeLa cells (de la Torre et al., 1990). The
rapid emergence of a fit virus strain following mutation of a sin-
gle nucleotide is perhaps more readily understood than a similar
event involving numerous loci which must all be different in order
for a fit population to arise. Nonetheless, postulating that enterovi-
ral replicative error continually tries out numerous possibilities
in an outstandingly large number of potential variations [with 16
mutated nucleotides, this is theoretically 416 potential variations!]
on a theme during virus passage, it can be seen that at some point,
a completely reverted wildtype sequence could reoccur providing
that the environment in which this process occurs is selective for
the wildtype population.
This argument then begs the question: would not intermediate
sequence populations be detectable? We  did not detect them. How-
ever, this is not equivalent to stating that intermediate (partially
reverted) CRE(2C) sequences did not occur or were not constantly
appearing and being discarded as non-competitive. Reversion of
the mutated CKO sequence to the wildtype CRE(2C) sequence
was constrained in at least three ways. Successful reversion to
wildtype must not only have regenerated an intact stem-loop sec-
ondary structure but not just any stem-loop; it must have, as well,
regenerated the structure’s function (i.e., the ability to enable uridy-
lylation). Reversion was further impacted by the requirement to
retain an intact reading frame for the protein 2C. To this point,
CRE(2C) sequence alignments (Fig. 4) revealed that non-wildtype
compensatory mutations which might have restored stem struc-
ture, would also have altered the protein 2C coding sequence.
Further, maintenance of the CRE(2C) loop region has been previ-
ously demonstrated to be under a stricter selection pressure than
expected for other regions of the genome (Goodfellow et al., 2000).
Our analysis of available EV-B 2C sequences to explore the possibil-
ity that non-wildtype compensatory mutations might arise within
the stem of the CRE(2C) (Fig. 4), together with the fact that all iden-
tified uridylylation CRE structures within EV genomes have a highly
conserved stem structure (Goodfellow et al., 2000; Paul et al., 2000;
van Ooij et al., 2006), are consistent with those findings and indi-
cate that sequences with compensatory mutations (which would be
expected in intermediate populations) would be less fit. Mutations
in the CRE(2C) loop have been infrequently reported in enterovirus
isolates (from analyses of sequences in GenBank; data not shown)
and point-mutational analysis done by others (van Ooij et al., 2006)
have demonstrated that single nucleotide changes in the loop of
the CRE(2C) inhibited the synthesis of the negative strand inter-
mediate and VPg uridylylation. Thus, it appears that altering the
CRE(2C) loop, even on a small scale, prevents efficient viral repli-
cation: the strong inference is that alterations in the EV 2C protein
coding sequence, including those in the CRE(2C) sequence, are not
advantageous to the virus.
These arguments are further strengthened by work (Crowder
and Kirkegaard, 2005), that may  further illuminate why stable viral
populations containing large amounts of intermediate (partially
mutated) CRE(2C) structures do not arise: some intermediate CRE
sequences generated during replication in any given cell may  actu-
ally hinder, rather than aid, reacquisition of the wildtype CRE(2C)
sequence. For example, two  synonymous double mutations within
just the stem of the poliovirus CRE(2C) structure expressed a dom-
inant negative effect in trans, inhibiting wildtype viral replication
in co-transfected cells, indicated by the decrease or absence of CPE
by the mutant strains (Crowder and Kirkegaard, 2005). However,
when the CRE(2C) structure was disrupted with 8 synonymous
mutations in both the stem and loop, not just the stem, domi-
nant negative effects were not observed (Crowder and Kirkegaard,
2005). We hypothesize that in our population of replicating TD-
CVB3-CKO, the very low level of RNA replication which occurs
is further affected by individual reversions that restore partial
CRE(2C) structure but which also exert a dominant-negative effect,
thereby lowering the replication of any variants which have suffi-
cient reversion of the structure to have any CRE(2C) function. Such
mutants cannot exert this dominant-negative effect on the CKO
variant, despite its reduced fitness, because it does not have a func-
tional CRE(2C) structure. Only when the population has enough
complete reversions of the CRE(2C) can the fitness of this popula-
tion allow it to more efficiently replicate than the genomes with the
complete CKO mutations. In becoming the dominant population, it
is to be recalled that a successfully competitive viral population
need only have a slight advantage (rate of replication, virion stabil-
ity, etc.) in order to completely replace another population (Clarke
et al., 1994; Martinez et al., 1991).
Yet another complication to the generation of a reverted CRE(2C)
population in any given cell, is that the CVB3 genomes lose the
wildtype 5′ genomic termini well before reversion of the CKO to
wildtype, thus becoming TD. This, by itself, dramatically slows viral
RNA replication although, as we  have previously shown (Smithee
et al., 2015), the TD and the CKO lesions are not significantly addi-
tive in their impact on suppressing replication. It is apparent that
a genome such as CVB3-TD50-CKO, which replicates with simi-
lar efficiency as either CVB3-TD50 or CVB3-CKO (Smithee et al.,
2015), indicates that the pressure to revert CKO to wildtype is not
only due to a requirement for more efficient positive strand RNA
replication. Because of this 5′ terminal deletion, reversions at the
CRE(2C) site do not generate a significant increase in replication in
the viral population. For this reason, the amplified cDNA in these
experiments does not reflect a large pool of template viral RNAs
and so, the probability of detecting the reverted CRE(2C) is low
until the completely reverted CRE(2C) dominates the population.
Because the CVB3 genome lost the wildtype 5′ genomic termini
prior to detection of the reverted (wildtype) CRE(2C) and because
full reversion to wildtype CRE(2C) still occurred when the CKO was
engineered into a CVB3-TD genome, we infer that there is a strong
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natural selection for a wildtype CRE(2C) in a CVB3 genome even in
the context of a positive strand RNA initiation that does not depend
upon VPg uridylylation.
One hypothesis to account for the drive to revert the CRE(2C)
site is that in a CVB-TD genome, CRE(2C) uridylylated VPg may  suf-
ficiently increase negative strand initiation over that which occurs
with the mutated CRE(2C) sequence. If true, this would imply that
the CRE(2C) has a role in for negative strand initiation in systems
in which positive strand initiation is not efficient. It is known from
work with poliovirus type 1 and with CVB3 that negative strand
initiation requires the 5′ end (domain I) and the CRE(2C) in addi-
tion to the wildtype 3′ end in order to replicate the negative strand
(Paul and Wimmer, 2015). Studies verified the importance of the
CRE(2C) for generation of the uridylylated protein primer (VPg or
precursors) for initiation of positive strand RNA but not for nega-
tive strand RNA replication (Barton and Flanegan, 1997; Goodfellow
et al., 2003b; Morasco et al., 2003; Murray and Barton, 2003). Cell
free replication systems for analysis of enterovirus RNA replica-
tion have been developed using guanidine hydrochloride which
inhibits initiation of negative strand RNA and the uridylylation
of the protein primer for initiation (VPg or precursors) to isolate
preinitiation replication complexes (PIRCs) (Barton et al., 1995;
Barton and Flanegan, 1997). Using these PIRCs with capsid deleted
replicons, it has been shown that deletion or alteration of structure
in domain I can cause a loss of efficiency of negative strand replica-
tion (Barton et al., 2001; Herold and Andino, 2001) but alterations
to the sequence of the presumed template for positive strand initi-
ation (the 3′ end of the negative strand) has strong effects upon
the efficiency of the generation of positive strand RNA (Sharma
et al., 2009; Vogt and Andino, 2010). Consistent with these findings,
previous work with CVB3-TD viruses has demonstrated a signifi-
cant decrease in positive strand RNA replication (Kim et al., 2005;
Smithee et al., 2015).
The study of the CVB3 CRE(2C) demonstrated that while nega-
tive strand replication (as measured as RF generated from positive
strand RNAs) is not affected by the DM mutations (identical to
the CKO mutations used in our study), single point mutations in
the CRE(2C) have the ability to lower negative strand replication
(van Ooij et al., 2006). Under limiting concentrations of UTP or CTP,
CRE(2C) generated uridylylated VPg increases efficiency of nega-
tive strand initiation in vitro (Steil and Barton, 2008). Many assays
of RF as an assay of negative strand initiation use limiting concen-
trations of UTP or CTP. These findings suggest that in limiting NTP
concentrations, replication in general is greatly lowered for the CKO
enterovirus and what is present is largely negative strand. The con-
ditions of our work with HeLa cells and in the mouse have a greater
concentration of these NTPs (Traut, 1994) which is likely to increase
the efficiency of negative strand RNA synthesis even in the context
of these CVB3-TD-CKO genomes.
As we know that the CKO replication generates 5′ terminal dele-
tions prior to the stage at which the CKO reversion to wildtype
occurs and occurs also in virus generated from a genome with both a
deletion of the 5′ terminal 49 nt and the CKO mutations, the context
in which reversion is occurring is in the mode of TD virus replica-
tion. The CVB3-TD viruses do not have an intact structure of stem
a of domain I but replicate both strands at nearly equal levels (Kim
et al., 2008; Kim et al., 2005) suggesting that the greatly decreased
production of positive strands in viral progeny also results in a
decrease in negative strand replication. The difference between a
NTP-limiting cell free in vitro environment and a living HeLa cell
may  affect extent and type of both positive and negative strand ini-
tiation but it must be acknowledged that cells and animals are the
natural environment for the replication of the enterovirus. As the
replication of TDs does not favor uridine residues in the 5′ ends of
positive strands, despite the fact that these genomes have cova-
lently attached VPg (Kim et al., 2005), positive strand initiation
does not occur via CRE(2C) uridylylated VPg. In these conditions,
the selection of a reverted CRE(2C) in replication suggests that
the functional CRE(2C) contributes to the fitness of TD genomes
via enhancing negative strand initiation. Alternatively, a functional
CRE(2C) may  have an as yet unidentified role in positive strand
initiation. Having shown that 5′ terminal genomic deletions occur
during replication of the CVB3-CKO genome, it is apparent that the
lack of a functional CRE(2C) is affecting the site and efficiency of ini-
tiation of the positive strand and potentially may  play a role other
than in production of uridylylated protein primer. Further work to
examine levels of each RNA strand during the process of reversion
might distinguish whether the selective pressure to revert the CKO
mutations in the CVB3-TD is due to a decrease in negative strand
replication alone and/or positive strand initiation.
Considering the foregoing discussion, we suggest a theoretical
mechanistic pathway for the observations reported here. Beginning
with the initial replication cycles of transfected infectious CVB3-
CKO RNA, errors are introduced into all new viral RNA strands at
an average rate between 1 and 3 nucleotide changes per each new
RNA molecule transcribed (Domingo et al., 2008; Holland et al.,
1982; Levi et al., 2010). Due to the input CKO mutations, viral
RNA replication is severely retarded relative to what is observed
with wildtype virus, significantly lowering the number of viral RNA
molecules in each infected cell. In the process of replication of this
mutated genome, 5′ terminal deletions occur, presumably due to
altered positive strand initiation. At the site of the CRE(2C), as each
new strand is replicated, only those errors that do not disrupt the
viral open reading frame will permit progression toward a new
and viable viral RNA generation. The mechanism by which the 16
CKO mutations revert to wildtype must clearly be a progressive,
albeit stochastic, process (Andino and Domingo, 2015; Domingo
and Holland, 1997; Holland et al., 1982; Jenkins et al., 2002). As well,
any mutations that act in trans with a dominant negative impact
(Crowder and Kirkegaard, 2005) will further narrow the bottleneck
through which viral genomes with accumulating correct CRE(2C)
reversions must pass. In the meantime, although the TD-CVB3-CKO
genome is replication-impaired, it nonetheless remains among the
most fit (able to replicate and package) of the nascent variations in
the population. That is, the TD-CVB3-CKO will proceed (albeit inef-
ficiently) to new generations while, at least initially, few variants
of this sequence will survive to build upon the previously toler-
ated mutations. Taken together, this reasonably accounts for the
observation that CKO is the CRE(2C) sequence that is repeatedly
detectable upon analysis following introduction to cells. Indeed, it
is also intriguing to consider that this may  occur because these CKO
genomes do not have a CRE(2C) structure which can be inhibited by
a trans-dominant negative effect from partially reverted genomes.
Yet this halting process changes once an intact wildtype CRE(2C) is
regenerated: this iteration is able to outcompete all others in the
population including those with the CKO mutations. Despite hav-
ing lost the 5′ genomic termini, this new population with an intact
CRE(2C) appears to have a slight but definite selective edge, and so
appears to occur ‘all at once’ rather than as in fact having endured an
exceptionally arduous journey through sequence space. As there is
selection at the CRE(2C) site for the wildtype sequence despite the
5′ terminal deletion uridylylated VPg-independent positive strand
initiation, this RNA structure plays a role in RNA replication in the
naturally occurring TD viruses.
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